HDx Therapy May Improve Patient-Reported Outcomes for Restless Leg Syndrome / La terapia HDx può migliorare i risultati riportati dai pazienti per la sindrome delle gambe senza riposo
HDx Therapy May Improve Patient-Reported Outcomes for Restless Leg Syndrome / La terapia HDx può migliorare i risultati riportati dai pazienti per la sindrome delle gambe senza riposo Segnalato dal Dott. Giuseppe Cotellessa / Reported by Dr. Giuseppe Cotellessa Expanded hemodialysis (HDx) enabled by Theranova may improve quality of life and patient-reported outcomes for end-stage renal disease patients meeting the criteria for Restless Leg Syndrome (RLS). RLS is a neurological disease, characterized by uncomfortable sensations inside the legs or arms. Its prevalence is much higher in ESRD patients than the general population. A large observational registry study conducted by Baxter found that the number of prevalent HD patients meeting Restless Leg Syndrome criteria were reduced by approximately 50% after six months of HDx therapy. Innovative HDx Supports Better Patient-Reported Quality of Life Patients on dialysis experience poor quality of life due to the symptoms of kidney failu